2001
DOI: 10.1016/s0304-8853(00)01256-7
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
66
0
1

Year Published

2003
2003
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 129 publications
(69 citation statements)
references
References 10 publications
0
66
0
1
Order By: Relevance
“…[9]), magnetically targeted drug and gene delivery (e.g. [2,3,6,12,18,19,20,21]), as well as separation under gravity (e.g. [5]).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[9]), magnetically targeted drug and gene delivery (e.g. [2,3,6,12,18,19,20,21]), as well as separation under gravity (e.g. [5]).…”
Section: Introductionmentioning
confidence: 99%
“…In the context of the former, and older technology, there have been two Phase I/II clinical trials [18,28] in addition to numerous in vivo studies (e.g. [2,3,19]). While the latter, newer technology has only been subject to a single combined in vitro and in vivo trial [20], it shows great promise.…”
Section: Introductionmentioning
confidence: 99%
“…Ferrofluids have a great potential for development in the medical applications, mechanical engineering, electronic packing aerospace, etc. [1][2][3][4]. The low toxicity and water-soluble qualities of some polymers such as poly(ethylene glycol), PEG make them suitable for industrial applications.…”
Section: Introductionmentioning
confidence: 99%
“…10 Some of the newest ferrofluid applications have been focused on their integration in a new technique for targeting disease treatment in the human body. [11][12][13][14][15] Magnetic drug targeting (MDT) involves magnetically guiding droplets of a biocompatible ferrofluid bonded reversibly to specific chemotherapeutic agents, which are injected into the blood or lymphatic circulation system. 15 Some trials performed on lab animals have shown that 50% of the typical systemic dose applied to treat cancerous tumors can result in remission of the tumor after only one treatment of anticancer drugs with MDT.…”
Section: Introductionmentioning
confidence: 99%
“…15 Some trials performed on lab animals have shown that 50% of the typical systemic dose applied to treat cancerous tumors can result in remission of the tumor after only one treatment of anticancer drugs with MDT. 11,[15][16][17] Though these studies have provided proof that the MDT application has promise as a clinical modality, only a few physics-based works have examined the interaction of the ferrofluid aggregate with an incident non-magnetic flow. Understanding the governing physics and scaling of the ferrofluid dispersion and retention could aid in the development of improved MDT methodologies.…”
Section: Introductionmentioning
confidence: 99%